253 related articles for article (PubMed ID: 25077735)
1. The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target.
Liu WY; Huang S; Shi KQ; Zhao CC; Chen LL; Braddock M; Chen YP; Feng WK; Zheng MH
Expert Opin Ther Targets; 2014 Nov; 18(11):1305-13. PubMed ID: 25077735
[TBL] [Abstract][Full Text] [Related]
2. Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.
Liu WY; Xie DM; Zhu GQ; Huang GQ; Lin YQ; Wang LR; Shi KQ; Hu B; Braddock M; Chen YP; Zheng MH
Expert Opin Ther Targets; 2015 May; 19(5):675-85. PubMed ID: 25547779
[TBL] [Abstract][Full Text] [Related]
3. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy.
Liu J; Xu Y; Hu Y; Wang G
Metabolism; 2015 Mar; 64(3):380-90. PubMed ID: 25516477
[TBL] [Abstract][Full Text] [Related]
4. FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
Ye M; Lu W; Wang X; Wang C; Abbruzzese JL; Liang G; Li X; Luo Y
Endocrinology; 2016 Dec; 157(12):4754-4769. PubMed ID: 27690692
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-21, energy balance and obesity.
Giralt M; Gavaldà-Navarro A; Villarroya F
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress.
Kim SH; Kim KH; Kim HK; Kim MJ; Back SH; Konishi M; Itoh N; Lee MS
Diabetologia; 2015 Apr; 58(4):809-18. PubMed ID: 25537833
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
8. Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses.
Salminen A; Kaarniranta K; Kauppinen A
Ageing Res Rev; 2017 Aug; 37():79-93. PubMed ID: 28552719
[TBL] [Abstract][Full Text] [Related]
9. Potential roles of fibroblast growth factor 21 in the brain.
Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.
So WY; Leung PS
Med Res Rev; 2016 Jul; 36(4):672-704. PubMed ID: 27031294
[TBL] [Abstract][Full Text] [Related]
12. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
13. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
14. FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance.
Szczepańska E; Gietka-Czernel M
Horm Metab Res; 2022 Apr; 54(4):203-211. PubMed ID: 35413740
[TBL] [Abstract][Full Text] [Related]
15. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
16. Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21.
Lu P; Yan J; Liu K; Garbacz WG; Wang P; Xu M; Ma X; Xie W
Hepatology; 2015 Jun; 61(6):1908-19. PubMed ID: 25614121
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.
Kralisch S; Fasshauer M
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):354-9. PubMed ID: 21505329
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Physiology of FGF21.
Fisher FM; Maratos-Flier E
Annu Rev Physiol; 2016; 78():223-41. PubMed ID: 26654352
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21: a regulator of metabolic disease and health span.
Xie T; Leung PS
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E292-E302. PubMed ID: 28559437
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
Woo YC; Xu A; Wang Y; Lam KS
Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
